407 related articles for article (PubMed ID: 38002264)
21. Wnt antagonist FRZB is a muscle biomarker of denervation atrophy in amyotrophic lateral sclerosis.
Kwan T; Kazamel M; Thoenes K; Si Y; Jiang N; King PH
Sci Rep; 2020 Oct; 10(1):16679. PubMed ID: 33028902
[TBL] [Abstract][Full Text] [Related]
22. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.
Thomsen GM; Gowing G; Latter J; Chen M; Vit JP; Staggenborg K; Avalos P; Alkaslasi M; Ferraiuolo L; Likhite S; Kaspar BK; Svendsen CN
J Neurosci; 2014 Nov; 34(47):15587-600. PubMed ID: 25411487
[TBL] [Abstract][Full Text] [Related]
23. Sporadic amyotrophic lateral sclerosis (SALS) - skeletal muscle response to cerebrospinal fluid from SALS patients in a rat model.
Shanmukha S; Narayanappa G; Nalini A; Alladi PA; Raju TR
Dis Model Mech; 2018 Apr; 11(4):. PubMed ID: 29666144
[TBL] [Abstract][Full Text] [Related]
24. [Systemic diseases of the motor neurons. Amyotrophic lateral sclerosis, spinal progressive muscular atrophy, progressive bulbar paralysis, spastic spinal paralysis, peripheral nerve muscular atrophy].
HIRAYAMA K
Naika; 1962 Dec; 10():1067-9. PubMed ID: 13954748
[No Abstract] [Full Text] [Related]
25. A robust TDP-43 knock-in mouse model of ALS.
Huang SL; Wu LS; Lee M; Chang CW; Cheng WC; Fang YS; Chen YR; Cheng PL; Shen CJ
Acta Neuropathol Commun; 2020 Jan; 8(1):3. PubMed ID: 31964415
[TBL] [Abstract][Full Text] [Related]
26. Single-cell RNA-seq analysis of the brainstem of mutant SOD1 mice reveals perturbed cell types and pathways of amyotrophic lateral sclerosis.
Liu W; Venugopal S; Majid S; Ahn IS; Diamante G; Hong J; Yang X; Chandler SH
Neurobiol Dis; 2020 Jul; 141():104877. PubMed ID: 32360664
[TBL] [Abstract][Full Text] [Related]
27. Amyotrophic lateral sclerosis and skeletal muscle: an update.
Pansarasa O; Rossi D; Berardinelli A; Cereda C
Mol Neurobiol; 2014 Apr; 49(2):984-90. PubMed ID: 24198230
[TBL] [Abstract][Full Text] [Related]
28. Androgens affect muscle, motor neuron, and survival in a mouse model of SOD1-related amyotrophic lateral sclerosis.
Aggarwal T; Polanco MJ; Scaramuzzino C; Rocchi A; Milioto C; Emionite L; Ognio E; Sambataro F; Galbiati M; Poletti A; Pennuto M
Neurobiol Aging; 2014 Aug; 35(8):1929-38. PubMed ID: 24630363
[TBL] [Abstract][Full Text] [Related]
29. Amyloid precursor protein (APP) contributes to pathology in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Bryson JB; Hobbs C; Parsons MJ; Bosch KD; Pandraud A; Walsh FS; Doherty P; Greensmith L
Hum Mol Genet; 2012 Sep; 21(17):3871-82. PubMed ID: 22678056
[TBL] [Abstract][Full Text] [Related]
30. Androgen receptor antagonism accelerates disease onset in the SOD1
McLeod VM; Lau CL; Chiam MDF; Rupasinghe TW; Roessner U; Djouma E; Boon WC; Turner BJ
Br J Pharmacol; 2019 Jul; 176(13):2111-2130. PubMed ID: 30849180
[TBL] [Abstract][Full Text] [Related]
31. Intact single muscle fibres from SOD1
Cheng AJ; Allodi I; Chaillou T; Schlittler M; Ivarsson N; Lanner JT; Thams S; Hedlund E; Andersson DC
J Physiol; 2019 Jun; 597(12):3133-3146. PubMed ID: 31074054
[TBL] [Abstract][Full Text] [Related]
32. Impaired bone homeostasis in amyotrophic lateral sclerosis mice with muscle atrophy.
Zhu K; Yi J; Xiao Y; Lai Y; Song P; Zheng W; Jiao H; Fan J; Wu C; Chen D; Zhou J; Xiao G
J Biol Chem; 2015 Mar; 290(13):8081-94. PubMed ID: 25648889
[TBL] [Abstract][Full Text] [Related]
33. Elevated PGC-1α activity sustains mitochondrial biogenesis and muscle function without extending survival in a mouse model of inherited ALS.
Da Cruz S; Parone PA; Lopes VS; Lillo C; McAlonis-Downes M; Lee SK; Vetto AP; Petrosyan S; Marsala M; Murphy AN; Williams DS; Spiegelman BM; Cleveland DW
Cell Metab; 2012 May; 15(5):778-86. PubMed ID: 22560226
[TBL] [Abstract][Full Text] [Related]
34. Bojungikgi-tang Improves Muscle and Spinal Cord Function in an Amyotrophic Lateral Sclerosis Model.
Cai M; Lee SH; Yang EJ
Mol Neurobiol; 2019 Apr; 56(4):2394-2407. PubMed ID: 30030751
[TBL] [Abstract][Full Text] [Related]
35. An optogenetic cell therapy to restore control of target muscles in an aggressive mouse model of amyotrophic lateral sclerosis.
Bryson JB; Kourgiantaki A; Jiang D; Demosthenous A; Greensmith L
Elife; 2024 Jan; 12():. PubMed ID: 38236205
[TBL] [Abstract][Full Text] [Related]
36. Cholinergic modulation of motor neurons through the C-boutons are necessary for the locomotor compensation for severe motor neuron loss during amyotrophic lateral sclerosis disease progression.
Landoni LM; Myles JR; Wells TL; Mayer WP; Akay T
Behav Brain Res; 2019 Sep; 369():111914. PubMed ID: 31022419
[TBL] [Abstract][Full Text] [Related]
37. Contingent intramuscular boosting of P2XR7 axis improves motor function in transgenic ALS mice.
Fabbrizio P; D'Agostino J; Margotta C; Mella G; Panini N; Pasetto L; Sammali E; Raggi F; Sorarù G; Bonetto V; Bendotti C; Nardo G
Cell Mol Life Sci; 2021 Dec; 79(1):7. PubMed ID: 34936028
[TBL] [Abstract][Full Text] [Related]
38. Severe muscle wasting and denervation in mice lacking the RNA-binding protein ZFP106.
Anderson DM; Cannavino J; Li H; Anderson KM; Nelson BR; McAnally J; Bezprozvannaya S; Liu Y; Lin W; Liu N; Bassel-Duby R; Olson EN
Proc Natl Acad Sci U S A; 2016 Aug; 113(31):E4494-503. PubMed ID: 27418600
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic targeting of epigenetic components in amyotrophic lateral sclerosis (ALS).
Lee J; Ryu H; Keum G; Yoon YJ; Kowall NW; Ryu H
Curr Med Chem; 2014; 21(31):3576-82. PubMed ID: 25005187
[TBL] [Abstract][Full Text] [Related]
40. Amyotrophic lateral sclerosis. Insights from genetics.
Brown RH
Arch Neurol; 1997 Oct; 54(10):1246-50. PubMed ID: 9341570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
